Qualitative serology in patients recovered from SARS CoV 2 infection.
作者信息
Bettencourt Paulo, Fernandes Catarina, Gil Ana, Almeida Antonio, Alvelos Margarida
机构信息
Hospital CUF Porto, Faculdade de Medicina da UP, Unidade de Investigação Cardiovascular da FMUP, Portugal.
Hospital CUF Porto, Faculdade de Medicina da UP, Unidade de Investigação Cardiovascular da FMUP, Portugal.
出版信息
J Infect. 2020 Aug;81(2):e120-e121. doi: 10.1016/j.jinf.2020.05.057. Epub 2020 May 28.
Abstract
摘要
相似文献
1
Qualitative serology in patients recovered from SARS CoV 2 infection.从新冠病毒感染中康复患者的定性血清学研究。
J Infect. 2020 Aug;81(2):e120-e121. doi: 10.1016/j.jinf.2020.05.057. Epub 2020 May 28.
2
Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?严重急性呼吸综合征冠状病毒2（SARS-CoV-2）血清学检测对新型冠状病毒肺炎（COVID-19）血液透析患者是否有意义？
Am J Kidney Dis. 2020 Oct;76(4):598. doi: 10.1053/j.ajkd.2020.06.006. Epub 2020 Jun 27.
3
Good IgA Bad IgG in SARS-CoV-2 Infection?新冠病毒感染中IgA有益而IgG有害？
Clin Infect Dis. 2020 Jul 28;71(15):897-898. doi: 10.1093/cid/ciaa426.
4
In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'.回复《严重急性呼吸综合征冠状病毒2型血清学对新冠肺炎血液透析患者是否有意义？》
Am J Kidney Dis. 2020 Oct;76(4):598-599. doi: 10.1053/j.ajkd.2020.06.005. Epub 2020 Jun 27.
5
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.新型冠状病毒肺炎患者中抗严重急性呼吸综合征冠状病毒2 IgM和IgG抗体的动态变化
J Infect. 2020 Aug;81(2):e55-e58. doi: 10.1016/j.jinf.2020.04.019. Epub 2020 Apr 23.
6
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies.三种用于检测抗SARS-CoV-2抗体的商用自动化检测方法的评估
Clin Chem. 2020 Oct 1;66(10):1351-1353. doi: 10.1093/clinchem/hvaa193.
7
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.新型冠状病毒2019感染病的血清学检测：益处、局限性与展望
Isr Med Assoc J. 2020 Apr;22(4):203-210.
8
A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).《关于〈2019年冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述：综述文章〉的评论》（《国际外科学杂志》2020年；81卷：第1 - 8页）
Int J Surg. 2020 Nov;83:28-29. doi: 10.1016/j.ijsu.2020.08.049. Epub 2020 Sep 11.
9
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?新型冠状病毒2型感染并发炎症综合征。静脉注射用大剂量人免疫球蛋白（IVIG）是否有益？
Autoimmun Rev. 2020 Jul;19(7):102559. doi: 10.1016/j.autrev.2020.102559. Epub 2020 May 1.
10
Mining the Antibody Repertoire for Solutions to SARS-CoV-2.从抗体库中寻找解决 SARS-CoV-2 的方法。
Cell Host Microbe. 2020 Oct 7;28(4):499-501. doi: 10.1016/j.chom.2020.09.010.
引用本文的文献
1
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
2
Guillain-Barré Syndrome in the COVID-19 Pandemic.新冠疫情中的吉兰-巴雷综合征
Neurol Int. 2021 Dec 24;14(1):34-48. doi: 10.3390/neurolint14010003.
3
SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort.妊娠期感染 SARS-CoV-2 及其相关结局：一项正在进行的前瞻性队列研究结果。
Paediatr Perinat Epidemiol. 2022 Jul;36(4):466-475. doi: 10.1111/ppe.12812. Epub 2021 Nov 21.
4
Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19.实验室检测结果在 COVID-19 的预防、诊断、治疗和监测中的应用。
Signal Transduct Target Ther. 2021 Aug 25;6(1):316. doi: 10.1038/s41392-021-00731-z.
5
The Role of Preprocedure Screening of SARS-CoV-2 Infection: A Tertiary Care Medical Center Analysis.严重急性呼吸综合征冠状病毒2感染的术前筛查作用：一家三级医疗中心的分析
GE Port J Gastroenterol. 2021 Jul 5;95814(1):1-7. doi: 10.1159/000516912.
6
Seroconversion among COVID-19 patients admitted in a dedicated COVID hospital: A longitudinal prospective study of 1000 patients.一家专门收治新冠肺炎患者的医院中新冠病毒抗体血清阳转情况：对1000例患者的纵向前瞻性研究。
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S379-S384. doi: 10.1016/j.mjafi.2021.06.007. Epub 2021 Jul 26.
7
Estimating the proportion and IgG antibody response to SARS-CoV-2 in individuals joining a central educational institute from different parts of India by Enzyme-linked immunosorbent assay (ELISA) based serology.通过基于酶联免疫吸附测定（ELISA）的血清学方法，估算来自印度不同地区、加入一所中央教育机构的个体中对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的感染比例及IgG抗体反应。
Med J Armed Forces India. 2021 Jul;77(Suppl 2):S366-S372. doi: 10.1016/j.mjafi.2021.02.008. Epub 2021 Jul 26.
8
Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19.检测 SARS-CoV-2 抗体不足以诊断活动性或已治愈的 COVID-19。
Sci Rep. 2020 Nov 16;10(1):19893. doi: 10.1038/s41598-020-76914-5.
本文引用的文献
1
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.感染 SARS-CoV-2 后的血清学特征：暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.
2
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients.新型冠状病毒肺炎患者中抗严重急性呼吸综合征冠状病毒2 IgM和IgG抗体的动态变化
J Infect. 2020 Aug;81(2):e55-e58. doi: 10.1016/j.jinf.2020.04.019. Epub 2020 Apr 23.
3
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department.VivaDiag新冠病毒IgM/IgG快速检测在用于急诊科急性患者的新冠病毒诊断时表现不佳。
J Med Virol. 2020 Oct;92(10):1724-1727. doi: 10.1002/jmv.25800. Epub 2020 Apr 8.
4
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).分析早期体液免疫反应以诊断新型冠状病毒病（COVID-19）。
Clin Infect Dis. 2020 Jul 28;71(15):778-785. doi: 10.1093/cid/ciaa310.
5
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.新型冠状病毒感染诊断用快速 IgM-IgG 联合抗体检测试剂的研制与临床应用
J Med Virol. 2020 Sep;92(9):1518-1524. doi: 10.1002/jmv.25727. Epub 2020 Apr 13.
6
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.2019-nCoV 感染患者的分子和血清学调查：多种脱落途径的意义。
Emerg Microbes Infect. 2020 Feb 17;9(1):386-389. doi: 10.1080/22221751.2020.1729071. eCollection 2020.
7
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.新型冠状病毒（2019-nCoV）引起肺炎爆发的分子诊断。
Clin Chem. 2020 Apr 1;66(4):549-555. doi: 10.1093/clinchem/hvaa029.
Zotero 插件